title: Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.
abstract: Wingless-type MMTV integration site family member (WNT) signaling and WNT-inhibitors have been implicated in regulation of adipogenesis, insulin resistance, pancreatic function, and inflammation. Our goal was to determine serum proteins involved in WNT signaling (WNT5 and WISP2) and WNT inhibition (SFRP4 and SFRP5) as they relate to obesity, serum adipokines, insulin resistance, insulin secretion, and inflammation in humans. Study population comprised 57 insulin resistant women with polycystic ovary syndrome (PCOS) and 27 reference women. In a cross-sectional study, blood samples were obtained at fasting, during oral, and frequently sampled intravenous glucose tolerance tests. Serum WNT5, WISP2, and SFRP4 concentrations did not differ between PCOS vs. reference women. Serum WNT5 correlated inversely with weight both in PCOS and reference women, and correlated directly with insulin response during oral glucose tolerance test in PCOS women. Serum WISP2 correlated directly with fatty acid binding protein 4. Serum SFRP5 did not differ between obese (n=32) vs. nonobese (n=25) PCOS women, but reference women had lower SFRP5 (p<5×10(-6) as compared to both PCOS groups). Serum SFRP5 correlated inversely with IL-1β, TNF-α, cholesterol, and apoprotein B. These findings demonstrated that WNT5 correlated inversely with adiposity and directly with insulin response, and the WNT-inhibitor SFRP5 may be anti-inflammatory. Better understanding of the role of WNT signaling in obesity, insulin resistance, insulin secretion, lipoprotein metabolism, and inflammation is important for prevention and treatment of metabolic syndrome, diabetes and cardiovascular disease.
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, The University of California at Davis, Davis, CA, USA.
authors.forename: R U
authors.initials: RU
authors.lastname: Almario
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, The University of California at Davis, Davis, CA, USA.
authors.forename: S E
authors.initials: SE
authors.lastname: Karakas
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D050154:Adiposity; D000328:Adult; D001055:Apolipoproteins B / Q000097:blood; D055511:CCN Intercellular Signaling Proteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D005136:Eye Proteins / Q000097:blood*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance; D000078790:Insulin Secretion; D053583:Interleukin-1beta / Q000097:blood; D008565:Membrane Proteins / Q000097:blood*; D008875:Middle Aged; D009765:Obesity / Q000097:blood; D011085:Polycystic Ovary Syndrome / Q000097:blood*; D011518:Proto-Oncogene Proteins / Q000097:blood*; D012097:Repressor Proteins / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D051153:Wnt Proteins / Q000097:blood*; D000094742:Secreted Frizzled-Related Proteins
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D001055:Apolipoproteins B; D055511:CCN Intercellular Signaling Proteins; D002784:Cholesterol; D005136:Eye Proteins; D007328:Insulin; D053583:Interleukin-1beta; D008565:Membrane Proteins; D011518:Proto-Oncogene Proteins; D012097:Repressor Proteins; D014409:Tumor Necrosis Factor-alpha; D051153:Wnt Proteins; C413323:CCN5 protein, human; C508585:IL1B protein, human; C118723:SFRP4 protein, human; D000094742:Secreted Frizzled-Related Proteins; C118511:SFRP5 protein, human